Serotonergic drug repurposing in multiple sclerosis: A new possibility for disease-modifying therapy

Investigation of neuroimmune interactions is one of the most developing areas in the study of multiple sclerosis pathogenesis. Recent evidence suggests the possibility of modulating neuroinflammation by targeting biogenic amine receptors. It has been shown that selective serotonin reuptake inhibitor...

Descripción completa

Detalles Bibliográficos
Autores principales: Melnikov, Mikhail, Kasatkin, Dmitriy, Lopatina, Anna, Spirin, Nikolay, Boyko, Alexey, Pashenkov, Mikhail
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9355384/
https://www.ncbi.nlm.nih.gov/pubmed/35937048
http://dx.doi.org/10.3389/fneur.2022.920408

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9355384/
https://www.ncbi.nlm.nih.gov/pubmed/35937048
http://dx.doi.org/10.3389/fneur.2022.920408

Ejemplares similares